GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Accumulated other comprehensive income (loss)

BioPharma Credit (LSE:BPCR) Accumulated other comprehensive income (loss) : $0.0 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. BioPharma Credit's Accumulated other comprehensive income (loss) for the quarter that ended in Dec. 2024 was $0.0 Mil.

BioPharma Credit Accumulated other comprehensive income (loss) Historical Data

The historical data trend for BioPharma Credit's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Accumulated other comprehensive income (loss) Chart

BioPharma Credit Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial - - - - -

BioPharma Credit Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

BioPharma Credit Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

BioPharma Credit Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
LSE:SDP LSE:ESCT LSE:JII LSE:IEM LSE:GSCT LSE:IAD LSE:ICGT LSE:MNTN LSE:USA LSE:CORD BLK KKR BX TSX:BAM OSTO:INVE A TSX:BN APO LSE:III AMP ARES
Traded in Other Exchanges
N/A
Address
29 Wellington Street, Central Square, Leeds, GBR, LS1 4DL
Website
https://www.bpcruk.com
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines